CPG Opioid Prescribing Guideline Examples
1.0.0 - ci-build
CPG Opioid Prescribing Guideline Examples
1.0.0 - ci-build
CPG Opioid Prescribing Guideline Examples, published by HL7 International - Clinical Decision Support WG. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cqframework/cpg-example-opioids/ and changes regularly. See the Directory of published versions
Contents:
This page provides a list of the FHIR artifacts defined as part of this implementation guide.
These define activities that can be performed as part of content in this implementation guide.
| CDC Opioid Prescribing Guideline Recommendation #7 - Risk Assessment ProcedureRequest |
As part of the workflow for recommendation 7, it is recommended that a risk assessment be conducted if the inclusion criteria is met. |
These define workflows, rules, strategies, or protocols as part of content in this implementation guide.
| CDC Opioid Prescribing Guideline Recommendation #5 |
When opioids are started, providers should prescribe the lowest effective dosage. |
These define logic, asset collections and other libraries as part of content in this implementation guide.
| OMTK Logic |
Opioid Management Terminology Knowledge Base Logic for use in implementing CDC Opioid Prescribing Guidelines. |
| Opioid CDS R4 Common Logic |
Common Opioid Decision Support Logic for use in implementing CDC Opioid Prescribing Guidelines. |
| Opioid CDS R4 Logic for recommendation #5 |
Opioid Decision Support Logic for use in implementing CDC Opioid Prescribing Guidelines. |
These define sets of codes used by systems conforming to this implementation guide.
| Opioids with Ambulatory Abuse Potential |
ValueSet containing an example subset of opioid medication formulations used in ambulatory settings that have the potential for misuse or abuse. Includes opioid drugs not restricted to surgical use that can be used in ambulatory setting. Excludes formulations with dose form Topical Cream(RXCUI 316982) or Topical Solution(RXCUI 316986) and ingredients available in surgery. NOTE: This is a deliberately reduced value set for example purposes. |